Previous 10 | Next 10 |
Viveve Medical (VIVE): Q1 GAAP EPS of -$0.80 misses by $0.29.Revenue of $1.45M (+11.5% Y/Y) beats by $0.12M.Shares +0.8%.Press Release For further details see: Viveve Medical EPS misses by $0.29, beats on revenue
Pivotal SUI PURSUIT trial enrollment underway and accelerating Total revenue of $1.5M for Q1 including sale of 2,450 consumable treatment tips Strengthened patent portfolio in key Asia Pacific markets ENGLEWOOD, CO / ACCESSWIRE / May 13, 2021 / Viveve Medical, Inc. (NASDAQ:VI...
Meeting scheduled to reconvene June 2, 2021 at 12:00 PM Eastern Time Company encourages stockholders to cast their votes ENGLEWOOD, CO / ACCESSWIRE / May 11, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announce...
InMode is a leader in the medical aesthetic devices industry and blows competitors out of the water when comparing financial metrics. The company still possesses many traits of a multi-bagger, such as having high revenue growth, stable margins, and high returns on capital. Our upd...
ENGLEWOOD, CO / ACCESSWIRE / May 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2021 financial results and provide a corporate update after the close of the U.S. financial ma...
Viveve Medical Inc. (NASDAQ:VIVE) traded at a new 52-week low today of $2.45. So far today approximately 2.3 million shares have been exchanged, as compared to an average 30-day volume of 879,000 shares. Viveve Medical Inc designs, develops, manufactures and markets a platform medical te...
ENGLEWOOD, CO / ACCESSWIRE / April 1, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Taiwan Intellectual Property Office (TIPO) recently issued Taiwan Patent No. 1720358 for Viveve's dual-energy technology ...
Viveve Medical, Inc. (VIVE) Q4 2020 Earnings Conference Call March 18, 2021 05:00 p.m. ET Company Representatives Scott Durbin - Chief Executive Officer Jeannie Swindle - Senior Director of Corporate Communications Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Ben Haynor - A...
Viveve Medical (VIVE): FY GAAP EPS of -$16.56 beats by $0.67.Revenue of $5.48M (-16.6% Y/Y) beats by $0.1M.Cash and cash equivalents were $6.5 million as of December 31, 2020, compared to $13.3 million as of December 31, 2019."Pending positive PURSUIT trial results in mid-2022 and subsequent ...
Company continuing to advance its U.S. pivotal PURSUIT trial in stress urinary incontinence Conference call to be hosted by Company at 5:00 PM ET today ENGLEWOOD, CO / ACCESSWIRE / March 18, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intim...
News, Short Squeeze, Breakout and More Instantly...
Novonix Limited (NVNXF) is expected to report for quarter end 2023-12-31 MedAvail Holdings Inc. (MDVL) is expected to report for Q3 2023 Nobility Homes, Inc. (NOBH) is expected to report for quarter end 2023-10-31 Walgreens Boots Alliance Inc. (WBA) is expected to report $0.66 for Q1 ...
Disco Corporation ADR (DSCSY) is expected to report for Q2 2024 Sonic Foundry Inc. (SOFO) is expected to report for quarter end 2023-09-30 Sono Group N.V. (SEVCQ) is expected to report for quarter end 2023-09-30 Minim Inc (MINM) is expected to report for Q3 2023 Enel Spa ADR (ENLA...
Enel Spa ADR (ENLAY) is expected to report for Q3 2023 LEG Immobilien SE Registered Shares (LEGIF) is expected to report for Q3 2023 G. Willi-Food International Ltd. (WILC) is expected to report for Q3 2023 Worthington Steel Inc. (WS) is expected to report $0.15 for Q2 2024 Sonic ...